Patient Education
Feb 16, 2026
AbstractBackgroundHeart failure is a clinical syndrome resulting from numerous pathological conditions. One cause of heart failure, transthyretin cardiac…
Feb 02, 2026
AbstractAmyloid transthyretin (ATTR) amyloidosis is a fatal disease caused by the accumulation of misfolded transthyretin proteins. Although knocking down the TTR…
Jan 27, 2026
Key PointsThis scoping review maps the earliest clinical signs of AL, ATTRwt, and ATTRv amyloidosis to improve early recognition and diagnosis.Distinct red flags…
Jan 21, 2026
Could CRISPR-Cas3 present itself as a potential therapeutic approach for genetic disorders like transthyretin amyloidosis (ATTR)?Researchers from the Institute of…
Jan 20, 2026
If you have transthyretin cardiac amyloidosis (ATTR-CM)external link, opens in a new tab, the same misshapen proteins that affect your heart can also build up…
Jan 13, 2026
AbstractBackgroundTransthyretin amyloid cardiomyopathy (ATTR-CM) is an increasingly recognized but still underdiagnosed cause of heart failure in older people,…
Jan 08, 2026
BackgroundSystemic light-chain (AL) amyloidosis is a rare plasma cell disorder with an annual incidence of approximately 8–12 cases per million population in…
Jan 05, 2026
AbstractWild-type transthyretin amyloidosis is a disease characterized by deposition of transthyretin amyloid protein in systemic organs and tissues, especially the…
Jan 02, 2026
If you’ve been diagnosed with amyloidosis, your doctor will assess how far the disease has progressed. This is called staging. As you go through amyloidosis…
Jan 02, 2026
Transthyretin amyloid cardiomyopathy (ATTR-CM) is a type of amyloidosis that affects the heart. It happens when a protein called transthyretin builds up in the…